UK markets closed

NIKKEI 225
38,073.98
-128.42(-0.34%)
HANG SENG
18,537.81
+223.91(+1.22%)
CRUDE OIL
79.67
+0.41(+0.52%)
GOLD FUTURES
2,352.90
+12.60(+0.54%)
DOW
39,387.76
+331.36(+0.85%)
Bitcoin GBP
50,576.11
+1,690.57(+3.46%)

Best UK mortgage deals of the week

As Bank of England holds interest rates, here's what high street banks are offering home buyers

SNDX May 2024 22.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.3000

0.0000

(0.00%)

As of 03:43PM EDT. Market open.

PR Newswire
Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference
Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of the Syndax management team will participate in a fireside chat at the Bank of America Securities 2024 Health Care Conference on Thursday, May 16, 2024, at 8:00 a.m. PT/ 11:00 a.m. ET.
GuruFocus.com
Syndax Pharmaceuticals Inc (SNDX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Insights into SNDX's robust pipeline progress, financial health, and strategic plans for upcoming drug launches.
PR Newswire
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the quarter ended March 31, 2024, and provided a business update.